Aeglemed Pharma Private Limited
About Aeglemed Pharma Private Limited
Data last updated:
Aeglemed Pharma Private Limited is a private limited company based in Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 19 September 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2022PTC404741.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹10,000. It is led by directors Neel Kamal Pandey and Pratibha Pandey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 388/1 – G No – 7/3 Part – 1 Sonia Vihar, Delhi, India – 110094.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.26 Lakh, a growth of 34% compared to the previous year. For the same year it recorded a net loss of ₹13,174 (net margin -5.8%) and EBITDA of -₹10,064 (EBITDA margin -4.5%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Aeglemed Pharma Private Limited's registered office is in Delhi, Delhi.
- Registered AddressA – 388/1 – G No – 7/3 Part – 1 Sonia Vihar, Delhi, India – 110094
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aeglemed Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aeglemed Pharma Private Limited, buy the company report.
Financials of Aeglemed Pharma Private Limited
FY 2025 filings availableAeglemed Pharma Private Limited reported revenue of ₹2.26 Lakh (up 34% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 34% in the latest year. EBITDA fell 428% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹10,064 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹13,174 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -4.5% | ||
| Net Profit Margin | -5.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Aeglemed Pharma Private Limited, buy the company report.
Board of directors of Aeglemed Pharma Private Limited
Aeglemed Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neel Kamal Pandey | Director | 19 Sep 2022 | 4 Years 1 Months | Current |
| Pratibha Pandey | Director | 19 Sep 2022 | 4 Years 1 Months | Current |
Peer comparison
Aeglemed Pharma Private Limited is compared with the 9 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Firetree Private Limited | ₹2.26 Lakh (FY 2025) | 1394.0% | Vellore, Tamil Nadu, India | |||
| Suvijay Distributors Pvt Ltd | ₹2.26 Lakh (FY 2019) | 2453.0% | Kolkata, West Bengal, India | |||
| Alpha Meditech Private Limited | ₹2.26 Lakh (FY 2018) | 37.0% | New Delhi, Delhi, India | |||
| Sudish World Solutions Private Limited | ₹2.26 Lakh (FY 2025) | 97.0% | Patna, Bihar, India | |||
| Aeglemed Pharma Private Limitedthis company | ₹2.26 Lakh (FY 2025) | -₹13,174 | -5.8% | 34.0% | Delhi, India | |
| Delhi Golf House (India) Private Limited | ₹2.26 Lakh (FY 2025) | -88.0% | New Delhi, Delhi, India | |||
| Super Balance Private Limited | ₹2.26 Lakh (FY 2025) | -96.0% | Dehradun, Uttarakhand, India | |||
| Wonderland Tradecomm Private Limited | ₹2.26 Lakh (FY 2025) | 6.0% | Bediadanga, West Bengal, India | |||
| Bivroshan Private Limited | ₹2.25 Lakh (FY 2024) | Simri Bakhtiarpur, Bihar, India | ||||
| Excelegal (OPC) Private Limited | ₹2.25 Lakh (FY 2025) | -81.0% | Mhowgaon, Mhow, Madhya Pradesh, India |
To see the full peer comparison of Aeglemed Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aeglemed Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aeglemed Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aeglemed Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aeglemed Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Neel Kamal Pandey was appointed as Director on 19 Sep 2022.
Frequently asked questions
Aeglemed Pharma is an active private limited company based in Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 19 September 2022 (4+ years old) and is registered under CIN U51909DL2022PTC404741.
Aeglemed Pharma has 2 current directors:
- Neel Kamal Pandey - Director
- Pratibha Pandey - Director
The latest financial statements of Aeglemed Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Aeglemed Pharma is U51909DL2022PTC404741. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aeglemed Pharma was incorporated on 19 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Aeglemed Pharma by revenue are Firetree Private Limited, Suvijay Distributors Pvt Ltd, Alpha Meditech Private Limited, Sudish World Solutions Private Limited, Delhi Golf House (India) Private Limited and 4 more, all in the same principal business activity (wholesale trading).
Neel Kamal Pandey was appointed as Director on 19 Sep 2022. Pratibha Pandey was appointed as Director on 19 Sep 2022.
The registered office of Aeglemed Pharma is at A – 3881 – G No – 73 Part – 1 Sonia Vihar, Delhi, India – 110094.
Aeglemed Pharma operates in the trading industry, in the specialty segment.
The compliance status of Aeglemed Pharma is compliant as of 17 August 2026. The company is actively filing with the Registrar of Companies.
Aeglemed Pharma can be reached at its registered office: A – 3881 – G No – 73 Part – 1 Sonia Vihar, Delhi, India – 110094.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
